Lionel Lim has more than 10 years of experience in project management, strategic marketing, and R&D in the health care sector.
Prior to joining Trendlines Medical Singapore, Lionel was a senior consultant with The Economist Intelligence Unit Healthcare, where he leads projects on growth advisory and commercial due diligence for merger & acquisition for fortune top 500 healthcare companies. He also worked with government agencies in Singapore to validate proof of concept and proof of value for medical devices.
Prior to The Economist, Lionel was a senior research associate at DX Assay, a start-up company which was supported by Economic Development Board Singapore (EDB) and Qiagen with the objective to develop the growth of personalized medicine.
He was also involved as a research associate with the Cancer Science Institute at National University of Singapore and Institute of Bioengineering and Nanotechnology.
Lionel received a BSc biotechnology (Hons) from the University of Queensland, Australia.